News
August 2008
Enrollment in second phase 3 LymphoStat-B(R) trial complete
Wednesday 27 Aug, 2008
Phase III results of VELCADE(R) (Bortezomib) for injection
Wednesday 27 Aug, 2008
Astra Zeneca assigned RSV Licence
Tuesday 26 Aug, 2008
SF1126 found to block angiogenic signaling
Tuesday 26 Aug, 2008
Favorable results from Phase I/IIa Pandemic influenza vaccine program
Tuesday 26 Aug, 2008
Advancement in FRANCIS trial
Monday 25 Aug, 2008
FDA Approves ALOXI(R) (Palonosetron HCl) Capsules
Sunday 24 Aug, 2008
Enrollment complete in Phase III Trial of PRO 2000 for Indevus Pharmaceuticals
Friday 22 Aug, 2008
Phase I/II trial of Pomalidomide in relapsed and refractory multiple myeloma patients
Friday 22 Aug, 2008
OGX-011 granted Fast Track designation by FDA
Friday 22 Aug, 2008
Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer
Friday 22 Aug, 2008
Research collaboration announced by Cryo-Cell International and EndGenitor Technologies
Thursday 21 Aug, 2008
FDA expanded approval to VIDAZA(R), to include overall survival in higher-risk MDS
Thursday 21 Aug, 2008
Regulatory clearance to commence clinical study of Bio Vex’s vaccine candidate for Genital Herpes: ImmunoVEX HSV2.
Wednesday 20 Aug, 2008
Affitech and Omeros collaborate for antibody discovery and development
Tuesday 19 Aug, 2008
BMP Sunstone receives SFDA approval to manufacture multivitamin granules
Monday 18 Aug, 2008
AstraZeneca partners with Singapore institutions to develop anti-cancer compounds
Sunday 17 Aug, 2008
FDA approval for XENAZINE(R) (Tetrabenazine) for patients with Chorea associated with Huntington's disease
Sunday 17 Aug, 2008
Morphotek®, inc. signs license agreement with NCI for the development of a monoclonal antibody to treat prostate cancer
Wednesday 13 Aug, 2008
The Multiple Myeloma Research Consortium (MMRC) announces initiation of four-drug combination study to treat newly diagnosed multiple Myeloma patients
Wednesday 13 Aug, 2008
Oxygen Biotherapeutics develops gel version of Oxycyte®
Tuesday 12 Aug, 2008
FDA appoints orphan drug status to STX-100
Tuesday 12 Aug, 2008
Carna Biosciences enters agreement with Caliper Life Sciences
Friday 8 Aug, 2008
Cipher Pharmaceuticals enters into agreement with Ranbaxy for CIP-ISOTRETINOIN
Wednesday 6 Aug, 2008
Nutra Pharma collaborates with Centers for disease control and prevention
Wednesday 6 Aug, 2008
Capricorn Pharma and Teva Pharmaceuticals enter agreement for KORKOAT technology
Tuesday 5 Aug, 2008
UBC and CogState Ltd. enter partnership for cognitive assessment in clinical trials
Tuesday 5 Aug, 2008
HCT and Exforge approved by US FDA for treatment of high blood pressure
Monday 4 Aug, 2008
Kowa Company, Ltd. acquires ProEthic Pharmaceuticals, Inc.
Monday 4 Aug, 2008
© 2008 Ochre Media. All rights reserved.